Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Taltorvic
US FDA rejects Merck/Ariad sarcoma drug
US FDA rejects Merck/Ariad sarcoma drug
Reuters
Ariad Pharmaceuticals
FDA
Merck
sarcoma
Taltorvic
4 Speculative Biotech Trades In The Economic Downturn
4 Speculative Biotech Trades In The Economic Downturn
Seeking Alpha
Ariad Pharmaceuticals
GSK
Horizant
Merck
postherpetic neuralgia
soft tissue sarcomas
Taltorvic
XenoPort
FDA panel does not recommend Taltorvic
FDA panel does not recommend Taltorvic
Reuters
advisory panels
Ariad Pharmaceuticals
FDA
Merck
soft tissue sarcomas
Taltorvic
Experts question Merck drug
Experts question Merck drug
Yahoo/Investors Business Daily
Merck
sarcoma
Taltorvic
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT